SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001086377-99-000002
Filing Date
1999-05-27
Accepted
1999-05-27 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 10317
  Complete submission text file 0001086377-99-000002.txt   12447
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-33655 | Film No.: 99636202
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACCESS PHARMACEUTICALS INC 2600 STEMMONS FRWY #176 DALLAS TX 75207-2107
Business Address C/O ACCESS PHARMACEUTICALS INC 2600 STEMMONS FRWY #176 DALLAS TX 75207-2107 2149055100
GRAY KERRY P (Filed by) CIK: 0001086377 (see all company filings)